Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05274321
Other study ID # 20-32530-OBS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 29, 2021
Est. completion date November 19, 2021

Study information

Verified date September 2023
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date November 19, 2021
Est. primary completion date November 19, 2021
Accepts healthy volunteers No
Gender All
Age group 2 Years to 17 Years
Eligibility Inclusion Criteria: - Participants under the age of 18 years old Exclusion Criteria: - Participants 18 years and older - Pupillary or anterior segment abnormality - Participants with pre-existing health conditions that would prevent pupillary dilation.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Nanodropper
Device used for administering eye drops
Standard Eye Dropper
Standard Eye Dropper used for administering eye drops

Locations

Country Name City State
United States University of California, San Francisco San Francisco California

Sponsors (2)

Lead Sponsor Collaborator
University of California, San Francisco Nanodropper, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Spherical Equivalent Cycloplegia is the paralysis of the ciliary muscle of the eye resulting in dilatation of the pupil and paralysis of accommodation.
Cycloplegia is defined as the "change score." Change scores were calculated by subtracting the spherical equivalent value after dilation from the value before dilation for each eye.
Before dilation and 30 minutes after dilation
Primary Maximum Pupil Diameter The pupil is the opening in the center of the iris (the structure that gives our eyes their color). The diameter is a straight line passing from side to side through the center of the pupil, which is shaped like a circle. Before dilation and 30 minutes after dilation
Primary Constriction Percentage Pupillary constriction percentage was calculated by the pupillometer in response to a 180-micro watt flash: (maximum - minimum) / maximum Before and 30 minutes after dilation
Secondary Change in Intraocular Pressure Intraocular pressure is the pressure, or force, inside of your eyes. Specifically, it's a measurement of the fluid pressure in your aqueous humor. Before and 30 minutes After Dilation
See also
  Status Clinical Trial Phase
Completed NCT05134974 - Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3) Phase 3
Completed NCT04620213 - Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis Phase 3
Not yet recruiting NCT06366217 - Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients Phase 4
Completed NCT05223478 - Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects Phase 3
Completed NCT04024891 - Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis Phase 2